These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
839 related articles for article (PubMed ID: 23404342)
1. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145. Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342 [TBL] [Abstract][Full Text] [Related]
2. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells. Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715 [TBL] [Abstract][Full Text] [Related]
3. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145. Guo W; Ren D; Chen X; Tu X; Huang S; Wang M; Song L; Zou X; Peng X J Cell Biochem; 2013 Jul; 114(7):1606-15. PubMed ID: 23355420 [TBL] [Abstract][Full Text] [Related]
4. miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells. Huang S; Guo W; Tang Y; Ren D; Zou X; Peng X Oncol Rep; 2012 Nov; 28(5):1831-7. PubMed ID: 22948942 [TBL] [Abstract][Full Text] [Related]
5. Loss of miR-100 enhances migration, invasion, epithelial-mesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2. Wang M; Ren D; Guo W; Wang Z; Huang S; Du H; Song L; Peng X Int J Oncol; 2014 Jul; 45(1):362-72. PubMed ID: 24805183 [TBL] [Abstract][Full Text] [Related]
6. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741 [TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4. Zhou JN; Zeng Q; Wang HY; Zhang B; Li ST; Nan X; Cao N; Fu CJ; Yan XL; Jia YL; Wang JX; Zhao AH; Li ZW; Li YH; Xie XY; Zhang XM; Dong Y; Xu YC; He LJ; Yue W; Pei XT Hepatology; 2015 Sep; 62(3):801-15. PubMed ID: 25953743 [TBL] [Abstract][Full Text] [Related]
9. N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells. Wang M; Ren D; Guo W; Huang S; Wang Z; Li Q; Du H; Song L; Peng X Int J Oncol; 2016 Feb; 48(2):595-606. PubMed ID: 26647992 [TBL] [Abstract][Full Text] [Related]
10. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887 [TBL] [Abstract][Full Text] [Related]
11. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer. Shi L; Jackstadt R; Siemens H; Li H; Kirchner T; Hermeking H Cancer Res; 2014 Jan; 74(2):532-42. PubMed ID: 24285725 [TBL] [Abstract][Full Text] [Related]
12. MiR-21 regulates epithelial-mesenchymal transition phenotype and hypoxia-inducible factor-1α expression in third-sphere forming breast cancer stem cell-like cells. Han M; Wang Y; Liu M; Bi X; Bao J; Zeng N; Zhu Z; Mo Z; Wu C; Chen X Cancer Sci; 2012 Jun; 103(6):1058-64. PubMed ID: 22435731 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-148a-3p suppresses epithelial-to-mesenchymal transition and stemness properties via Wnt1-mediated Wnt/β-catenin pathway in pancreatic cancer. Fu X; Hong L; Yang Z; Tu Y; Xin W; Zha M; Tu S; Sun G; Li Y; Xiao W J Cell Mol Med; 2020 Nov; 24(22):13020-13035. PubMed ID: 33026174 [TBL] [Abstract][Full Text] [Related]
14. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2. Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway. Huang K; Tang Y; He L; Dai Y Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483 [TBL] [Abstract][Full Text] [Related]
16. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells. Nam EH; Lee Y; Park YK; Lee JW; Kim S Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells. Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882 [TBL] [Abstract][Full Text] [Related]
19. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1. Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430 [TBL] [Abstract][Full Text] [Related]
20. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis. Yu CC; Chen PN; Peng CY; Yu CH; Chou MY Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]